Egfrm2Btlr/Egfrm2Btlr
C57BL/6J-Egfrm2Btlr
|
disheveled coat |
J:231805
|
|
rough coat |
J:231805
|
|
thick skin |
J:231805
|
EgfrMhdadsk5/Egfr+
C3HeB/FeJ-EgfrMhdadsk5/Ieg
|
abnormal nail morphology |
J:81301
|
|
abnormal skin pigmentation |
J:81301
|
|
increased foot pad pigmentation |
J:81301
|
|
thick epidermis |
J:81301
|
|
waved hair |
J:81301
|
EgfrMhdadsk5/Egfr+
involves: 129S1/SvImJ * C3HeB/FeJ
|
increased susceptibility to Coronaviridae infection |
J:243599
|
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality |
J:243599
|
EgfrMhdadsk5/EgfrMhdadsk5
involves: C3HeB/FeJ * C57BL/6J
|
abnormal skin pigmentation |
J:81301
|
|
increased foot pad pigmentation |
J:81301
|
|
long toenails |
J:81301
|
|
thick epidermis |
J:81301
|
|
waved hair |
J:81301
|
Egfrtm1.1Dwt/Egfrtm1.1Dwt
involves: 129S6/SvEvTac
|
abnormal dorsal root ganglion morphology |
J:145069
|
|
abnormal hair follicle morphology |
J:145069
|
|
abnormal sensory neuron innervation pattern |
J:145069
|
Egfrtm1.1Tyj/Egfrtm1.1Tyj
involves: 129 * C57BL/6
|
embryonic lethality, complete penetrance |
J:101977
|
Egfrtm1a(EUCOMM)Wtsi/Egfr+
C57BL/6N-Egfrtm1a(EUCOMM)Wtsi/Wtsi
|
decreased leukocyte cell number |
J:175295
|
Egfrtm1Dwt/Egfrtm1Dwt
Sox9tm3(cre)Crm/Sox9+
involves: 129S6/SvEvTac * 129S7/SvEvBrd
|
abnormal epidermal layer morphology |
J:229771
|
|
abnormal skin morphology |
J:229771
|
|
dermatitis |
J:229771
|
|
impaired skin barrier function |
J:229771
|
|
increased IgE level |
J:229771
|
|
increased T-helper 1 cell number |
J:229771
|
|
increased T-helper 2 cell number |
J:229771
|
|
increased T-helper 17 cell number |
J:229771
|
Egfrtm1Dwt/Egfrtm1Dwt
Tg(EIIa-cre)C5379Lmgd/0
involves: 129S6/SvEvTac * C57BL/6J * FVB/N
|
abnormal placenta labyrinth morphology |
J:145161
|
|
abnormal spongiotrophoblast layer morphology |
J:145161
|
|
decreased embryo size |
J:145161
|
|
placental labyrinth hypoplasia |
J:145161
|
Egfrtm1Dwt/Egfrtm1Dwt
Tg(KRT14-cre)1Amc/0
involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA
|
waved hair |
J:145161
|
Egfrtm1Dwt/Egfrtm1Dwt
Tg(KRT14-cre)1Amc/0
involves: 129S6/SvEvTac * C57BL/6 * CBA
|
abnormal hair follicle morphology |
J:145069
|
|
normal
nervous system phenotype |
J:145069
|
Egfrtm1Dwt/Egfrtm1Mag
involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J
|
normal
growth/size/body region phenotype |
J:145161
|
|
normal
integument phenotype |
J:145161
|
|
normal
reproductive system phenotype |
J:145161
|
Egfrtm1Mag/Egfrtm1Mag
involves: 129/Sv * 129S2/SvPas
|
abnormal placenta labyrinth morphology |
J:26833
|
|
decreased spongiotrophoblast size |
J:26833
|
|
decreased trophoblast giant cell number |
J:26833
|
|
embryonic lethality at implantation, complete penetrance |
J:26833
|
|
embryonic lethality during organogenesis, complete penetrance |
J:26833
|
|
perinatal lethality, complete penetrance |
J:26833
|
|
small placenta |
J:26833
|
Egfrtm1Mag/Egfrtm1Mag
involves: 129S2/SvPas * CD-1
|
abnormal cerebellum external granule cell layer morphology |
J:26833
|
|
abnormal cerebral cortex morphology |
J:26833
|
|
abnormal coat appearance |
J:26833
|
|
abnormal colon morphology |
J:26833
|
|
abnormal esophageal epithelium morphology |
J:26833
|
|
abnormal filiform papillae morphology |
J:26833
|
|
abnormal fungiform papillae morphology |
J:26833
|
|
abnormal hair follicle development |
J:26833
|
|
abnormal hair follicle inner root sheath morphology |
J:26833
|
|
abnormal hair follicle orientation |
J:26833
|
|
abnormal hair shaft morphology |
J:26833
|
|
abnormal hepatocyte morphology |
J:26833
|
|
abnormal liver morphology |
J:26833
|
|
abnormal lung development |
J:26833
|
|
abnormal olfactory bulb morphology |
J:26833
|
|
abnormal tongue morphology |
J:26833
|
|
absent eyelids |
J:26833
|
|
cachexia |
J:26833
|
|
curly vibrissae |
J:26833
|
|
decreased brain size |
J:26833
|
|
decreased Purkinje cell number |
J:26833
|
|
delayed hair appearance |
J:26833
|
|
dilated kidney collecting duct |
J:26833
|
|
distorted hair follicle pattern |
J:26833
|
|
eyelids open at birth |
J:26833
|
|
increased blood urea nitrogen level |
J:26833
|
|
increased circulating creatinine level |
J:26833
|
|
perinatal lethality, complete penetrance |
J:26833
|
|
postnatal growth retardation |
J:26833
|
|
small cerebellum |
J:26833
|
|
thin cerebral cortex |
J:26833
|
|
wavy vibrissae |
J:26833
|
Egfrtm1Mag/Egfrtm1Mag
involves: 129S2/SvPas * CF-1
|
abnormal inner cell mass morphology |
J:26833
|
|
embryonic lethality between implantation and somite formation, incomplete penetrance |
J:26833
|
Egfrtm1Mag/Egfrwa2
involves: 129S2/SvPas * B6EiC3Sn a/A-Egfrwa2 Wnt3avt * CD-1
|
thick aortic valve |
J:60750
|
Egfrtm1Msi/Egfrtm1Msi
Tg(Alb1-cre)7Gsc/?
involves: 129P2/OlaHsd * C57BL/6 * FVB/N
|
delayed liver regeneration |
J:125912
|
|
increased circulating tumor necrosis factor level |
J:125912
|
|
increased susceptibility to induced morbidity/mortality |
J:125912
|
|
slow postnatal weight gain |
J:125912
|
Egfrtm1Msi/Egfrtm1Msi
Tg(Mx1-cre)1Cgn/?
involves: 129P2/OlaHsd * C57BL/6 * CBA
|
delayed liver regeneration |
J:125912
|
|
increased circulating tumor necrosis factor level |
J:125912
|
|
increased susceptibility to induced morbidity/mortality |
J:125912
|
Egfrtm1Rdk/Egfrtm1Rdk
involves: 129X1/SvJ * Black Swiss
|
abnormal branching involved in lung morphogenesis |
J:41158
|
|
abnormal bronchus morphology |
J:27464,
J:41158
|
|
abnormal epidermis stratum basale morphology |
J:27464
|
|
abnormal epidermis stratum granulosum morphology |
J:27464
|
|
abnormal exocrine pancreas morphology |
J:62160
|
|
abnormal hair follicle development |
J:27464
|
|
abnormal hair growth |
J:27464
|
|
abnormal intestinal absorption |
J:27464
|
|
abnormal intestine morphology |
J:27464
|
|
abnormal lung interstitium morphology |
J:41158
|
|
abnormal outer ear morphology |
J:27464
|
|
abnormal pancreas morphology |
J:62160
|
|
abnormal pancreatic beta cell morphology |
J:62160
|
|
abnormal pulmonary acinus morphology |
J:41158
|
|
abnormal pulmonary alveolus morphology |
J:27464,
J:41158
|
|
abnormal pulmonary interalveolar septum morphology |
J:41158
|
|
abnormal skin appearance |
J:27464
|
|
abnormal submandibular gland branching morphogenesis |
J:69420
|
|
abnormal terminal bronchiole morphology |
J:41158
|
|
abnormal tongue epithelium morphology |
J:27464
|
|
abnormal type II pneumocyte morphology |
J:41158
|
|
atelectasis |
J:41158
|
|
cleft palate |
J:27464,
J:54535
|
|
curly vibrissae |
J:27464
|
|
cyanosis |
J:41158
|
|
decreased alveolar lamellar body number |
J:41158
|
|
decreased body size |
J:27464
|
|
decreased embryo size |
J:27464
|
|
decreased fetal size |
J:27464
|
|
dilated respiratory conducting tube |
J:41158
|
|
dilated terminal bronchiole tube |
J:41158
|
|
disorganized pancreatic islets |
J:62160
|
|
dry skin |
J:27464
|
|
embryonic lethality during organogenesis, incomplete penetrance |
J:27464
|
|
eyelids open at birth |
J:27464
|
|
flaky skin |
J:27464
|
|
fused cornea and lens |
J:27464
|
|
hematoma |
J:27464
|
|
impaired lung alveolus development |
J:41158
|
|
increased heart rate |
J:27464
|
|
petechiae |
J:27464
|
|
pointed snout |
J:54535
|
|
postnatal lethality, complete penetrance |
J:27464
|
|
respiratory distress |
J:41158
|
|
respiratory failure |
J:41158
|
|
short mandible |
J:54535
|
|
small Meckel's cartilage |
J:54535
|
|
small pancreas |
J:62160
|
|
small placenta |
J:27464
|
|
thick pulmonary interalveolar septum |
J:27464,
J:41158
|
|
thin epidermis |
J:27464
|
|
weight loss |
J:27464
|
Egfrtm1Wag/Egfrtm1Wag
involves: 129
|
decreased embryo size |
J:26834
|
|
decreased embryo weight |
J:26834
|
|
embryonic lethality during organogenesis, complete penetrance |
J:26834
|
|
small placenta |
J:26834
|
Egfrtm1Wag/Egfrtm1Wag
involves: 129 * C57BL/6
|
abnormal bronchiole epithelium morphology |
J:26834
|
|
abnormal epidermal layer morphology |
J:26834
|
|
abnormal epidermis stratum corneum morphology |
J:26834
|
|
abnormal hair follicle morphology |
J:26834
|
|
abnormal maternal decidual layer morphology |
J:26834
|
|
abnormal placenta morphology |
J:26834
|
|
abnormal pulmonary alveolus epithelium morphology |
J:26834
|
|
abnormal vibrissa morphology |
J:26834
|
|
absent vibrissae |
J:26834
|
|
decreased cornea thickness |
J:26834
|
|
decreased embryo size |
J:26834
|
|
decreased embryo weight |
J:26834
|
|
decreased spongiotrophoblast size |
J:26834
|
|
embryonic lethality during organogenesis, incomplete penetrance |
J:26834
|
|
eyelids open at birth |
J:26834
|
|
lethality throughout fetal growth and development, incomplete penetrance |
J:26834
|
|
postnatal lethality, complete penetrance |
J:26834
|
|
small placenta |
J:26834
|
|
thick pulmonary interalveolar septum |
J:26834
|
|
thin epidermis |
J:26834
|
Egfrtm1Wag/Egfrtm1Wag
involves: 129 * C57BL/6 * MF1
|
cachexia |
J:26834
|
|
decreased body weight |
J:26834
|
|
dehydration |
J:26834
|
|
postnatal lethality, incomplete penetrance |
J:26834
|
EgfrVel/Egfr+
involves: C57BL/6J
|
abnormal eyelid development |
J:88776
|
|
abnormal eyelid morphology |
J:88776
|
|
abnormal hair follicle orientation |
J:88776
|
|
corneal opacity |
J:88776
|
|
curly vibrissae |
J:88776
|
|
decreased fibroblast cell migration |
J:88776
|
|
eyelids open at birth |
J:88776
|
|
failure of eyelid fusion |
J:88776
|
|
microphthalmia |
J:88776
|
|
plush coat |
J:88776
|
|
waved hair |
J:88776
|
|
weight loss |
J:166602
|
EgfrVel/EgfrVel
involves: C57BL/6J
|
abnormal trophoblast layer morphology |
J:88776
|
|
embryonic lethality during organogenesis, complete penetrance |
J:88776
|
|
placental labyrinth hypoplasia |
J:88776
|
Egfrwa2-4J/Egfrwa2-4J
involves: C57BL/6J * DBA/2J
|
waved hair |
J:78380
|
Egfrwa2/Egfrwa2
B6EiC3Sn a/A-Egfrwa2 Wnt3avt/J
|
abnormal hair texture |
J:16986
|
|
abnormal lactation |
J:23326
|
|
abnormal mammary gland morphology |
J:23326
|
|
abnormal vibrissa morphology |
J:16986
|
|
enlarged aortic valve |
J:60750
|
|
thick aortic valve |
J:60750
|
Egfrwa2/Egfrwa2
involves: C57BL/6
|
abnormal aorta morphology |
J:241813
|
|
abnormal aortic valve morphology |
J:241813
|
|
abnormal heart left ventricle morphology |
J:241813
|
|
abnormal heart valve physiology |
J:241813
|
|
abnormal myocardial fiber morphology |
J:241813
|
|
aortic valve regurgitation |
J:241813
|
|
aortic valve stenosis |
J:241813
|
|
calcified aortic valve |
J:241813
|
|
cardiac fibrosis |
J:241813
|
|
decreased ventricle muscle contractility |
J:241813
|
|
heart left ventricle hypertrophy |
J:241813
|
|
increased cardiac stroke volume |
J:241813
|
|
increased heart left ventricle size |
J:241813
|
|
increased pulse pressure |
J:241813
|
Egfrwa2/Egfrwa2
STOCK ac
|
abnormal eye morphology |
J:15329
|
|
abnormal hair cortex keratinization |
J:5260
|
|
abnormal hair medulla |
J:5260
|
|
cataract |
J:15329
|
|
curly vibrissae |
J:13052
|
|
decreased body size |
J:13052
|
|
increased curvature of guard hairs |
J:13052
|
|
increased curvature of hairs |
J:5260
|
|
short hair |
J:13052
|
|
short vibrissae |
J:13052
|
|
waved hair |
J:5260,
J:13052
|
Egfrwa2/Egfrwa2
STOCK Egfrwa2
|
abnormal aortic valve morphology |
J:60750
|
|
aortic valve regurgitation |
J:60750
|
|
enlarged semilunar valve |
J:60750
|
|
increased left ventricle systolic pressure |
J:60750
|
|
prolonged PR interval |
J:60750
|
|
prolonged RR interval |
J:60750
|
Egfrwa2/EgfrWa5
involves: BALB/cAnN * C3H/HeN * C57BL/6J
|
abnormal eye morphology |
J:92308
|
|
abnormal fertility/fecundity |
J:92308
|
|
abnormal vagina orifice morphology |
J:92308
|
|
alopecia |
J:92308
|
|
asymmetric snout |
J:92308
|
|
decreased body weight |
J:92308
|
|
long snout |
J:92308
|
|
loss of vibrissae |
J:92308
|
|
mandible hypoplasia |
J:92308
|
|
narrow snout |
J:92308
|
|
perinatal lethality, incomplete penetrance |
J:92308
|
|
postnatal growth retardation |
J:92308
|
|
postnatal lethality, incomplete penetrance |
J:92308
|
EgfrWa5/Egfr+
involves: BALB/cAnN * C3H/HeN
|
abnormal eye morphology |
J:75964
|
|
abnormal hair texture |
J:75964
|
|
abnormal vibrissa morphology |
J:75964
|
|
corneal scarring |
J:75964
|
|
curly vibrissae |
J:75964
|
|
eyelids open at birth |
J:75964
|
|
waved hair |
J:75964
|
EgfrWa5/Egfr+
involves: BALB/cAnN * C3H/HeN * C57BL/6J
|
abnormal placenta labyrinth morphology |
J:92308
|
|
abnormal placenta morphology |
J:92308
|
|
decreased spongiotrophoblast size |
J:92308
|
EgfrWa5/EgfrWa5
involves: BALB/cAnN * C3H/HeN
|
preweaning lethality, complete penetrance |
J:75964
|
EgfrWa5/EgfrWa5
involves: BALB/cAnN * C3H/HeN * C57BL/6J
|
abnormal placenta labyrinth morphology |
J:92308
|
|
abnormal placenta morphology |
J:92308
|
|
decreased spongiotrophoblast size |
J:92308
|
|
embryonic lethality during organogenesis, incomplete penetrance |
J:92308
|
|
lethality throughout fetal growth and development, incomplete penetrance |
J:92308
|
Tg(Gh1-rtTA)4-3Jek/0
Tg(tetO-Egfr*)2-9Jek/0
involves: C57BL/6 * SJL
|
abnormal gonadotroph morphology |
J:68692
|
|
abnormal reproductive system physiology |
J:68692
|
|
decreased body size |
J:68692
|
|
decreased lactotroph cell number |
J:68692
|
|
decreased somatotroph cell number |
J:68692
|
|
delayed eyelid opening |
J:68692
|
|
postnatal growth retardation |
J:68692
|
|
postnatal lethality |
J:68692
|
|
slow postnatal weight gain |
J:68692
|
|
small adenohypophysis |
J:68692
|
Tg(Prl-tTA)6-5Jek/0
Tg(tetO-Egfr*)2-9Jek/0
involves: C57BL/6 * SJL
|
normal
endocrine/exocrine gland phenotype |
J:68692
|
|
normal
growth/size/body region phenotype |
J:68692
|
|
normal
homeostasis/metabolism phenotype |
J:68692
|
|
normal
reproductive system phenotype |
J:68692
|
Excel File
Analysis Tools